5-Bromo-2-oxindole → HCID 67280999, compound
Reaction equation
[Br:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6](=[O:11])[CH2:5]2.[CH3:12][N:13]1[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][CH2:21][NH:22][C:23]([C:25]2[C:29]([C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=3)=[C:28]([CH:36]=O)[NH:27][C:26]=2[CH:38]([CH3:40])[CH3:39])=[O:24])[CH2:15][CH2:14]1>>[CH3:12][N:13]1[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][CH2:21][NH:22][C:23]([C:25]2[C:29]([C:30]3[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=3)=[C:28]([CH:36]=[C:5]3[C:4]4[C:8](=[CH:9][CH:10]=[C:2]([Br:1])[CH:3]=4)[NH:7][C:6]3=[O:11])[NH:27][C:26]=2[CH:38]([CH3:40])[CH3:39])=[O:24])[CH2:15][CH2:14]1Participants
3
Procedure
5-Bromo-1,3-dihydroindol-2-one (53 mg, 0.25 mmol) was condensed with 5-formyl-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid [3-(4-methylpiperazin-1-yl)propyl]amide (300 mg to give 65 mg of the title compound.
Sources & evidence
- ORD record
- ord-3af1149214564c8db9b8803a2fe36c3a
- Source dataset
- uspto-grants-2005_04
- Patent number
- US06878733B1
Reaction notes
Loading…